90 yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: Updated results after a median follow-up of 8.5 years from the GOTEL trial

Authors :: Fernando Franco
Francisco Ramon Garcia Arroyo
Luis de la Cruz-Merino
Ruth Alvarez
Ana Royuela
Mariano Provencio-Pulla
Juan Ramón Delgado
Antonio Rueda
José Gómez-Codina
Marta Llanos
Cristina Quero
Jose Ignacio Chacon
Josep Guma
Source :: Journal of Clinical Oncology. 36:7550-7550
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 7550Background: Relapse is the main cause of therapeutic failure in follicular lymphoma (FL). We report updated long-term efficacy and toxicity results of a multicenter phase II study (GOTEL-Proven...

Tools